KKR Provides $600 Million Financing to Indian Conglomerate Manipal Group

8 months ago

Transaction marks KKR’s latest and largest credit investment in IndiaMUMBAI, India--(BUSINESS WIRE)--KKR, a leading global investment firm, and Manipal Education…

Kenanga Investors Launches New Global Real Asset Fund

8 months ago

The Kenanga Alternative Series: Global Real Assets Fund offers investors exposure primarily to global real estate, precious metals, and commodities…

MarkHerz Signs MOU with TUM Hospital for Joint Development of Cardiovascular and Diabetes-Targeted AAV Gene Therapies

8 months ago

Paving the Way for European Clinical Entry and Global Technology Transfer A Milestone Partnership Highlighting Korea’s Expanding Influence in Global…

ImmunAbs Announces FDA Phase 2 IND Approval of IM-101, a Novel Complement C5 Inhibitor, for Treatment of Myasthenia Gravis

8 months ago

SEOUL, South Korea--(BUSINESS WIRE)--ImmunAbs Inc., a clinical-stage biotech specializing in developing antibody therapeutics, today announced that the U.S. Food and…

Software Launches for SCIEX OS Ecosystem to Help Scientists Accelerate Discoveries and Streamline Lab Operations

8 months ago

MARLBOROUGH, Mass.--(BUSINESS WIRE)--#AI--SCIEX, a global leader in life science analytical technologies and operating company of Danaher Corporation (NYSE: DHR), announces…

Zai Lab Presents Positive Phase 1 Data for ZL-1310, a DLL3-Targeted ADC, Demonstrating Robust Anti-Tumor Activity and Safety in Patients with Extensive-Stage Small Cell Lung Cancer at 2025 ASCO Annual Meeting

8 months ago

- Clinically meaningful anti-tumor activity of ZL-1310 observed in heavily pretreated population of patients with small cell lung cancer (SCLC)…

James Hardie Industries plc Announces Proposed Private Offering of Senior Secured Notes

8 months ago

SYDNEY--(BUSINESS WIRE)--James Hardie Industries plc (ASX: JHX) (“James Hardie” or the “Company”) announced today that its wholly-owned subsidiary, JH North…

AEye’s Apollo Lidar Sensor Wins Prestigious AIIA Intelligent Perception Industry Leadership Award

8 months ago

PLEASANTON, Calif.--(BUSINESS WIRE)--AEye, Inc. (Nasdaq: LIDR), a global leader in adaptive, high-performance lidar solutions, announced today that its flagship 1550…

ENHERTU® Plus Pertuzumab Reduced the Risk of Disease Progression or Death by 44% Versus THP as First-Line Therapy in Patients with HER2 Positive Metastatic Breast Cancer in DESTINY-Breast09 Phase 3 Trial

8 months ago

Daiichi Sankyo and AstraZeneca’s ENHERTU plus pertuzumab showed a median progression-free survival greater than three years First trial in more…

UiPath Partners with HCLTech to Accelerate Agentic Automation for Global Enterprises

8 months ago

NEW YORK & NOIDA, India--(BUSINESS WIRE)--UiPath (NYSE: PATH), a global leader in agentic automation, today announced a strategic partnership with…